Will March 2012 Mark The End Of Regulatory Limbo For Discovery's Surfaxin?

FDA has set a March 6 user fee date for action on Discovery Laboratories' synthetic surfactant, which was filed with the agency in 2004 but is now in its fifth review cycle.

More from Archive

More from Pink Sheet